Clinical Trial Update: Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia

View source ↗

Summary

This completed study provides pharmacogenomic validation for response to imatinib in patients with chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Asan Medical Center | Conditions: Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Status: COMPLETED